Total synthesis of herbimycin A
Sophie Canova1, Véronique Bellosta, Antony Bigot
1Laboratoire de Chimie Organique, associé au CNRS, ESPI, 10 rue Vauquelin, 75231 Paris Cedex 05, France.
Organic Letters
|December 29, 2006
Summary
Researchers synthesized Herbimycin A, a natural product that inhibits Heat Shock Protein 90 (Hsp90). This synthesis provides a potential pathway for developing new cancer treatments targeting Hsp90 activity.
Area of Science:
- Organic Chemistry
- Medicinal Chemistry
- Molecular Biology
Background:
- Heat Shock Protein 90 (Hsp90) is a key molecular chaperone implicated in cancer progression.
- Hsp90 is a validated therapeutic target for various cancers.
- Herbimycin A, a benzoquinoid ansamycin, is a known inhibitor of Hsp90 activity.
Purpose of the Study:
- To achieve the total synthesis of Herbimycin A.
- To establish a synthetic route for generating Hsp90 inhibitors.
- To explore novel strategies for cancer treatment development.
Main Methods:
- Total synthesis of Herbimycin A from Roche ester 1.
- Utilized allylmetals for stereoselective control of multiple chiral centers (C6, C7, C10, C11, C12).
- Employed ring-closing metathesis to establish the (Z)-double bond within the (E,Z)-dienic moiety.
Main Results:
- Successful total synthesis of Herbimycin A was accomplished.
- The synthetic strategy effectively controlled key stereogenic centers.
- The (Z)-double bond formation was successfully achieved via ring-closing metathesis.
Conclusions:
- The total synthesis of Herbimycin A provides a viable route for its production.
- This synthesis offers a foundation for developing novel Hsp90-targeting cancer therapies.
- The established methodology can be applied to the synthesis of related ansamycin compounds.
More Related Videos
Related Concept Videos
01:27Production of Antibiotics
Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
01:27Combined Effects of Drugs: Synergism
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
01:18Production of Biopesticides
Biopesticides offer a sustainable alternative to chemical pesticides, utilizing microbial agents to control agricultural pests. Bacillus thuringiensis (Bt) is a widely employed bacterium known for its potent insecticidal activity. Bt biopesticides are favored for their specificity to insect pests, minimal environmental impact, and natural degradability.Mechanism of Bt Toxin Action Bt produces insecticidal crystal (Cry) proteins during its sporulation phase. These proteins form parasporal...
01:30Production of Pharmaceuticals
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...